NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1254006585|ref|NP_001343606|]
View 

Transcription initiation factor TFIID subunit 2 [Caenorhabditis elegans]

Protein Classification

transcription initiation factor TFIID subunit 2( domain architecture ID 10177047)

transcription initiation factor TFIID subunit 2 is a component of transcription factor TFIID, which is one of the general factors required for accurate and regulated initiation by RNA polymerase II

Gene Ontology:  GO:0005669|GO:0006357

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
73-558 4.85e-135

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


:

Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 419.33  E-value: 4.85e-135
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585   73 ILSQQVEIsNLNISTRSFNVRTEIVLLPCEKSLYQLDLHIGKCSLlpnevpgsaSKVTLNGVECEYSRRDFWKDLAQ-EK 151
Cdd:cd09839      1 VAHQKVEL-DVDFANRSIIGYTEITIVPTSPDLRTIRLNCRQCKI---------KSVTVNGVEAEFTYNDPLQNLDLsDN 70
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  152 SISSLEPVLYEKLAENDY-------ELQILIPKEVRKKIKHR-------------------KAVRLRVDTVVRDPPRGLQ 205
Cdd:cd09839     71 TDVNAHHELKRKLAAALAepdegneELVISLPPSVKIELQDPnsastqattsspdtsedefTPLTIRIEYSLKNPRDGLH 150
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  206 FVDFNE----HDCHVFTYHTPHISGAREWTVCLDEPDQLALWELTF-----------------------------ELEPH 252
Cdd:cd09839    151 FVGPDEggdkRYPHVYTTNSPLPGSARCWFPCVDSLWERCTWELEItvprtlgdagrpplagskededdddlteeDKELE 230
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  253 LVPVASGELEEKREVSEN-GKIRYKFHQTVPTSACNIGWAIGRFKLEPHPE-------------SPTIYTFSLPGLEPFV 318
Cdd:cd09839    231 MVVVCSGDLVEQVVHPEDpSKKTFSFSLSNPTSAQHIGFAVGPFEIVPLPEfreseeddklgssAVEVTGFCLPGRLEEL 310
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  319 NHTTMYLDKMVEFLEEkLSCRFPYPTLKVVFVDQCTEEIQVYSSLLIVPTAMLYHKKIIDVVQEARQKLIFSIALQFFGC 398
Cdd:cd09839    311 RNTCSFLHKAMDFFEE-EYGSYPFSSYKQVFVDDLPEDVSSFASLSICSSRLLYPPDIIDQAYETRRKLAHALASQWFGI 389
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  399 LISPAQWWHWWIPVSIARFLTSLYVETKLGTAEARWQLKRAMDDVCDYEHQwgkivlsppeptkKLPLHVDPRHEYTaSP 478
Cdd:cd09839    390 NIIPKTWSDTWLVIGIAGYMTGLFLKKLFGNNEYRFRIKKDADRVCELDIG-------------RPPLAQPGFILPL-DP 455
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  479 LYVEAMLKKGFLTMRMLQRRIGLEPFMRVLHRVLTVGLDmsekKTTPAAWRHLLTTTESFFRSVISVTGKEIPSFLSQFV 558
Cdd:cd09839    456 SELEFMALKAPLVLFILDRRLTKTGGSFGLSRVLPKIFL----QAMSGDLSNNALSTSHFLRTCEKVSGNKLESFFDQWV 531
 
Name Accession Description Interval E-value
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
73-558 4.85e-135

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 419.33  E-value: 4.85e-135
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585   73 ILSQQVEIsNLNISTRSFNVRTEIVLLPCEKSLYQLDLHIGKCSLlpnevpgsaSKVTLNGVECEYSRRDFWKDLAQ-EK 151
Cdd:cd09839      1 VAHQKVEL-DVDFANRSIIGYTEITIVPTSPDLRTIRLNCRQCKI---------KSVTVNGVEAEFTYNDPLQNLDLsDN 70
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  152 SISSLEPVLYEKLAENDY-------ELQILIPKEVRKKIKHR-------------------KAVRLRVDTVVRDPPRGLQ 205
Cdd:cd09839     71 TDVNAHHELKRKLAAALAepdegneELVISLPPSVKIELQDPnsastqattsspdtsedefTPLTIRIEYSLKNPRDGLH 150
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  206 FVDFNE----HDCHVFTYHTPHISGAREWTVCLDEPDQLALWELTF-----------------------------ELEPH 252
Cdd:cd09839    151 FVGPDEggdkRYPHVYTTNSPLPGSARCWFPCVDSLWERCTWELEItvprtlgdagrpplagskededdddlteeDKELE 230
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  253 LVPVASGELEEKREVSEN-GKIRYKFHQTVPTSACNIGWAIGRFKLEPHPE-------------SPTIYTFSLPGLEPFV 318
Cdd:cd09839    231 MVVVCSGDLVEQVVHPEDpSKKTFSFSLSNPTSAQHIGFAVGPFEIVPLPEfreseeddklgssAVEVTGFCLPGRLEEL 310
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  319 NHTTMYLDKMVEFLEEkLSCRFPYPTLKVVFVDQCTEEIQVYSSLLIVPTAMLYHKKIIDVVQEARQKLIFSIALQFFGC 398
Cdd:cd09839    311 RNTCSFLHKAMDFFEE-EYGSYPFSSYKQVFVDDLPEDVSSFASLSICSSRLLYPPDIIDQAYETRRKLAHALASQWFGI 389
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  399 LISPAQWWHWWIPVSIARFLTSLYVETKLGTAEARWQLKRAMDDVCDYEHQwgkivlsppeptkKLPLHVDPRHEYTaSP 478
Cdd:cd09839    390 NIIPKTWSDTWLVIGIAGYMTGLFLKKLFGNNEYRFRIKKDADRVCELDIG-------------RPPLAQPGFILPL-DP 455
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  479 LYVEAMLKKGFLTMRMLQRRIGLEPFMRVLHRVLTVGLDmsekKTTPAAWRHLLTTTESFFRSVISVTGKEIPSFLSQFV 558
Cdd:cd09839    456 SELEFMALKAPLVLFILDRRLTKTGGSFGLSRVLPKIFL----QAMSGDLSNNALSTSHFLRTCEKVSGNKLESFFDQWV 531
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
71-708 8.92e-31

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 129.38  E-value: 8.92e-31
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585   71 FRILSQQVEIsNLNISTRSFNVRTEIVLLPCEKSLYQLDLHigkcsLLPNEVpgsaSKVTLNGVECEYSRrdfwkdlaqe 150
Cdd:COG0308     15 YDVTHYDLDL-DLDPATTRLSGTATITFTATEAPLDSLVLD-----LKGLEV----TSVTVDGKPLDFTR---------- 74
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  151 ksisslepvlyeklaeNDYELQILIPKEVRKKIKHRkaVRLRVDTVVRDPPRGLQFVDFNEHDCH-VFTYHTPHisGARE 229
Cdd:COG0308     75 ----------------DGERLTITLPKPLAPGETFT--LEIEYSGKPSNGGEGLYRSGDPPDGPPyLYTQCEPE--GARR 134
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  230 WTVCLDEPDQLALWELTFELEPHLVPVASGELEEKREVsENGKIRYKFHQTVPTSACNIGWAIGRFKL--EPHPESPTIY 307
Cdd:COG0308    135 WFPCFDHPDDKATFTLTVTVPAGWVAVSNGNLVSETEL-GDGRTTWHWADTQPIPTYLFALAAGDYAVveDTFASGVPLR 213
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  308 TFSLPGLEPFVNHTTMYLDKMVEFLEEKLSCRFPYPTLKVVFVDQ----------CTeeiqVY-SSLLIVPTAMLYHKKI 376
Cdd:COG0308    214 VYVRPGLADKAKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVPDfnfgamenqgLV----TFgEKVLADETATDADYER 289
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  377 ID--VVQEarqklifsIALQFFGCLISPAQWWHWWIPVSIARFLTSLYVETKLGTAEARWQLKRAMDDvcdyehqwgkIV 454
Cdd:COG0308    290 REsvIAHE--------LAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYGKDAADRIFVGALRS----------YA 351
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  455 LSPPEPTKKLPLHVDPRHEytASPLYVEAMLKKGFLTMRMLQRRIGLEPFMRVLHRVLtvgldmsekkttpAAWRHLLTT 534
Cdd:COG0308    352 FAEDAGPNAHPIRPDDYPE--IENFFDGIVYEKGALVLHMLRTLLGDEAFRAGLRLYF-------------ARHAGGNAT 416
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  535 TESFFRSVISVTGKEIPSFLSQFVRTGGHAAFAVKFDFNRKRNiVEIEIKQDDTEGngrtqYTGPLSVVVQEVDGAFTHT 614
Cdd:COG0308    417 TEDFLAALEEASGRDLSAFFDQWLYQAGLPTLEVEYEYDADGK-VTLTLRQTPPRP-----HPFHIPLEVGLLGGKLTAR 490
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  615 iqidgavshaeischskgrkqrkkkVPLLTGEEIEIDltnmDAESPILWLRIDPDYLLIREiTISQPMFHWEYMLRYERD 694
Cdd:COG0308    491 -------------------------TVLLDGEQTELV----AKPDPVLLLRLDDELAFLLA-HDSDPFNRWEALQALWRD 540
                          650
                   ....*....|....
gi 1254006585  695 viAQMEALERIQAL 708
Cdd:COG0308    541 --GEADYLDALRAL 552
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
106-284 1.61e-07

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 52.73  E-value: 1.61e-07
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  106 YQLDLHI--------GKCS--LLPNEvpgSASKVTLNGVECEYSRrdfwkdLAQEKSISSLEPVLYEKLAENDYELQILI 175
Cdd:pfam17900    5 YDLDLKIdlknftfsGSVTitLQLNN---ATNVIVLHASDLTIRS------ISLSDEVTSDGVPADFTEDQKDGEKLTIV 75
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  176 PKEVRKKIKHrkaVRLRVD--TVVRDPPRGLQ---FVDFNEHDCHVFTYHTPHisGAREWTVCLDEPDQLALWELTFELE 250
Cdd:pfam17900   76 LPETLNQTGP---YTLEIEysGELNDSMTGFYrstYTDNGEKKVLVTTQFEPT--DARSAFPCFDEPSVKATFTISIIHP 150
                          170       180       190
                   ....*....|....*....|....*....|....
gi 1254006585  251 PHLVpVASGELEEKREVSENGKIRYKFHQTVPTS 284
Cdd:pfam17900  151 KDYT-ALSNMPVIASEPLENGWVITTFEQTPKMS 183
 
Name Accession Description Interval E-value
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
73-558 4.85e-135

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 419.33  E-value: 4.85e-135
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585   73 ILSQQVEIsNLNISTRSFNVRTEIVLLPCEKSLYQLDLHIGKCSLlpnevpgsaSKVTLNGVECEYSRRDFWKDLAQ-EK 151
Cdd:cd09839      1 VAHQKVEL-DVDFANRSIIGYTEITIVPTSPDLRTIRLNCRQCKI---------KSVTVNGVEAEFTYNDPLQNLDLsDN 70
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  152 SISSLEPVLYEKLAENDY-------ELQILIPKEVRKKIKHR-------------------KAVRLRVDTVVRDPPRGLQ 205
Cdd:cd09839     71 TDVNAHHELKRKLAAALAepdegneELVISLPPSVKIELQDPnsastqattsspdtsedefTPLTIRIEYSLKNPRDGLH 150
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  206 FVDFNE----HDCHVFTYHTPHISGAREWTVCLDEPDQLALWELTF-----------------------------ELEPH 252
Cdd:cd09839    151 FVGPDEggdkRYPHVYTTNSPLPGSARCWFPCVDSLWERCTWELEItvprtlgdagrpplagskededdddlteeDKELE 230
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  253 LVPVASGELEEKREVSEN-GKIRYKFHQTVPTSACNIGWAIGRFKLEPHPE-------------SPTIYTFSLPGLEPFV 318
Cdd:cd09839    231 MVVVCSGDLVEQVVHPEDpSKKTFSFSLSNPTSAQHIGFAVGPFEIVPLPEfreseeddklgssAVEVTGFCLPGRLEEL 310
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  319 NHTTMYLDKMVEFLEEkLSCRFPYPTLKVVFVDQCTEEIQVYSSLLIVPTAMLYHKKIIDVVQEARQKLIFSIALQFFGC 398
Cdd:cd09839    311 RNTCSFLHKAMDFFEE-EYGSYPFSSYKQVFVDDLPEDVSSFASLSICSSRLLYPPDIIDQAYETRRKLAHALASQWFGI 389
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  399 LISPAQWWHWWIPVSIARFLTSLYVETKLGTAEARWQLKRAMDDVCDYEHQwgkivlsppeptkKLPLHVDPRHEYTaSP 478
Cdd:cd09839    390 NIIPKTWSDTWLVIGIAGYMTGLFLKKLFGNNEYRFRIKKDADRVCELDIG-------------RPPLAQPGFILPL-DP 455
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  479 LYVEAMLKKGFLTMRMLQRRIGLEPFMRVLHRVLTVGLDmsekKTTPAAWRHLLTTTESFFRSVISVTGKEIPSFLSQFV 558
Cdd:cd09839    456 SELEFMALKAPLVLFILDRRLTKTGGSFGLSRVLPKIFL----QAMSGDLSNNALSTSHFLRTCEKVSGNKLESFFDQWV 531
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
71-708 8.92e-31

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 129.38  E-value: 8.92e-31
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585   71 FRILSQQVEIsNLNISTRSFNVRTEIVLLPCEKSLYQLDLHigkcsLLPNEVpgsaSKVTLNGVECEYSRrdfwkdlaqe 150
Cdd:COG0308     15 YDVTHYDLDL-DLDPATTRLSGTATITFTATEAPLDSLVLD-----LKGLEV----TSVTVDGKPLDFTR---------- 74
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  151 ksisslepvlyeklaeNDYELQILIPKEVRKKIKHRkaVRLRVDTVVRDPPRGLQFVDFNEHDCH-VFTYHTPHisGARE 229
Cdd:COG0308     75 ----------------DGERLTITLPKPLAPGETFT--LEIEYSGKPSNGGEGLYRSGDPPDGPPyLYTQCEPE--GARR 134
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  230 WTVCLDEPDQLALWELTFELEPHLVPVASGELEEKREVsENGKIRYKFHQTVPTSACNIGWAIGRFKL--EPHPESPTIY 307
Cdd:COG0308    135 WFPCFDHPDDKATFTLTVTVPAGWVAVSNGNLVSETEL-GDGRTTWHWADTQPIPTYLFALAAGDYAVveDTFASGVPLR 213
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  308 TFSLPGLEPFVNHTTMYLDKMVEFLEEKLSCRFPYPTLKVVFVDQ----------CTeeiqVY-SSLLIVPTAMLYHKKI 376
Cdd:COG0308    214 VYVRPGLADKAKEAFESTKRMLDFFEELFGVPYPFDKYDQVAVPDfnfgamenqgLV----TFgEKVLADETATDADYER 289
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  377 ID--VVQEarqklifsIALQFFGCLISPAQWWHWWIPVSIARFLTSLYVETKLGTAEARWQLKRAMDDvcdyehqwgkIV 454
Cdd:COG0308    290 REsvIAHE--------LAHQWFGNLVTCADWDDLWLNEGFATYMEQLFSEDLYGKDAADRIFVGALRS----------YA 351
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  455 LSPPEPTKKLPLHVDPRHEytASPLYVEAMLKKGFLTMRMLQRRIGLEPFMRVLHRVLtvgldmsekkttpAAWRHLLTT 534
Cdd:COG0308    352 FAEDAGPNAHPIRPDDYPE--IENFFDGIVYEKGALVLHMLRTLLGDEAFRAGLRLYF-------------ARHAGGNAT 416
                          490       500       510       520       530       540       550       560
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  535 TESFFRSVISVTGKEIPSFLSQFVRTGGHAAFAVKFDFNRKRNiVEIEIKQDDTEGngrtqYTGPLSVVVQEVDGAFTHT 614
Cdd:COG0308    417 TEDFLAALEEASGRDLSAFFDQWLYQAGLPTLEVEYEYDADGK-VTLTLRQTPPRP-----HPFHIPLEVGLLGGKLTAR 490
                          570       580       590       600       610       620       630       640
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  615 iqidgavshaeischskgrkqrkkkVPLLTGEEIEIDltnmDAESPILWLRIDPDYLLIREiTISQPMFHWEYMLRYERD 694
Cdd:COG0308    491 -------------------------TVLLDGEQTELV----AKPDPVLLLRLDDELAFLLA-HDSDPFNRWEALQALWRD 540
                          650
                   ....*....|....
gi 1254006585  695 viAQMEALERIQAL 708
Cdd:COG0308    541 --GEADYLDALRAL 552
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
107-559 9.45e-24

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 105.36  E-value: 9.45e-24
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  107 QLDLHigkcsllpnevPGSASKVTLNGVECEYSRRDfwkdlaqeksisslepvlyeklaenDYELQILIPKEVRKKikhr 186
Cdd:cd09603     37 QLDLV-----------GLTVSSVTVDGVPAAFFTHD-------------------------GDKLVITLPRPLAAG---- 76
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  187 KAVRLRVDTVVRdPPRGLQFVDFNEHDCH----VFTYHTPHisGAREWTVCLDEPDQLALWELTFELEPHLVPVASGELE 262
Cdd:cd09603     77 ETFTVTVRYSGK-PRPAGYPPGDGGGWEEgddgVWTAGQPE--GASTWFPCNDHPDDKATYDITVTVPAGLTVVSNGRLV 153
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  263 EKREvSENGKIRYKFHQTVPTSACNIGWAIGRFKLEPHPESPTI--YTFSLPGLEPFVNHTTMYLDKMVEFLEEKLsCRF 340
Cdd:cd09603    154 STTT-NGGGTTTWHWKMDYPIATYLVTLAVGRYAVVEDGSGGGIplRYYVPPGDAAKAKASFARTPEMLDFFEELF-GPY 231
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  341 PYPTLKVVFVDqcteeiqvyssllIVPTAM------LYHKKIIDVVQEARQKLIFSIALQFFGCLISPAQWWHWWIPVSI 414
Cdd:cd09603    232 PFEKYGQVVVP-------------DLGGGMehqtatTYGNNFLNGDRGSERLIAHELAHQWFGDSVTCADWADIWLNEGF 298
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  415 ARFLTSLYVETKLGTAEARWQLKRAMDDVcdyehqwgkIVLSPPEPTKKLPLHVDPRHEYtasplyveamlKKGFLTMRM 494
Cdd:cd09603    299 ATYAEWLWSEHKGGADAYRAYLAGQRQDY---------LNADPGPGRPPDPDDLFDRDVY-----------QKGALVLHM 358
                          410       420       430       440       450       460
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1254006585  495 LQRRIGLEPFMRVLHRVLtvgldmsekkttpAAWRHLLTTTESFFRSVISVTGKEIPSFLSQFVR 559
Cdd:cd09603    359 LRNLLGDEAFFAALRAYL-------------ARYAHGNVTTEDFIAAAEEVSGRDLTWFFDQWLY 410
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
226-506 2.34e-09

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 60.92  E-value: 2.34e-09
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  226 GAREWTVCLDEPDQLALWELTFELEPHLVpVASGELEEKREVSENGKIRYKFHQTVPTSACNIGWAIGRFklephpESPT 305
Cdd:cd09595    115 HARRIFPCIDHPAVKATFTVTITTPKKDL-LASNGALVGEETGANGRKTYRFEDTPPIPTYLVAVVVGDL------EFKY 187
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  306 IYTFSLPGLEPFVNHTTMYLDK----------MVEFLEEKLSCRFPYPTLKVVFVDQCTEEIQVYSSLLIVPTAMLYHKK 375
Cdd:cd09595    188 VTVKSQPRVGLSVYSEPLQVDQaqyafdatraALAWFEDYFGGPYPLPKYDLLAVPDFNSGAMENPGLITFRTTYLLRSK 267
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  376 IIDVVQEARQKLI-FSIALQFFGCLISPAQWWHWWIPVSIARFLTSLYVETKLGTAearwqlKRAMDDVCDYEHQWGKIV 454
Cdd:cd09595    268 VTDTGARSIENVIaHELAHQWFGNLVTMRWWNDLWLNEGFAVYYENRIMDATFGTS------SRHLDQLSGSSDLNTEQL 341
                          250       260       270       280       290
                   ....*....|....*....|....*....|....*....|....*....|...
gi 1254006585  455 LSPPEPTK-KLPLHVDPRHEYTASPlYVeamlkKGFLTMRMLQRRIGLEPFMR 506
Cdd:cd09595    342 LEDSSPTStPVRSPADPDVAYDGVT-YA-----KGALVLRMLEELVGEEAFDK 388
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
106-284 1.61e-07

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 52.73  E-value: 1.61e-07
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  106 YQLDLHI--------GKCS--LLPNEvpgSASKVTLNGVECEYSRrdfwkdLAQEKSISSLEPVLYEKLAENDYELQILI 175
Cdd:pfam17900    5 YDLDLKIdlknftfsGSVTitLQLNN---ATNVIVLHASDLTIRS------ISLSDEVTSDGVPADFTEDQKDGEKLTIV 75
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  176 PKEVRKKIKHrkaVRLRVD--TVVRDPPRGLQ---FVDFNEHDCHVFTYHTPHisGAREWTVCLDEPDQLALWELTFELE 250
Cdd:pfam17900   76 LPETLNQTGP---YTLEIEysGELNDSMTGFYrstYTDNGEKKVLVTTQFEPT--DARSAFPCFDEPSVKATFTISIIHP 150
                          170       180       190
                   ....*....|....*....|....*....|....
gi 1254006585  251 PHLVpVASGELEEKREVSENGKIRYKFHQTVPTS 284
Cdd:pfam17900  151 KDYT-ALSNMPVIASEPLENGWVITTFEQTPKMS 183
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
327-513 1.02e-06

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 50.75  E-value: 1.02e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  327 KMVEFLEEKLSCRFPYPTLKVVFVDQ----------CTeeIQVYSSLLIVP--TAMLYHKKIIDVVQEarqklifSIALQ 394
Cdd:pfam01433    8 KLLEFYEDYFNIPYPLPKYDLVALPDfsagamenwgLI--TYRETLLLYDPgnSSTSDKQRVASVIAH-------ELAHQ 78
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  395 FFGCLISPAQWWHWWIPVSIARFLTSLYVETKLGTAEAR-----WQLKRAM-DDVCDYEHqwgkivlsppeptkklPLHV 468
Cdd:pfam01433   79 WFGNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIWeqfllDEVQNAMaRDALDSSH----------------PITQ 142
                          170       180       190       200
                   ....*....|....*....|....*....|....*....|....*
gi 1254006585  469 DPRHEYTASPLYVEAMLKKGFLTMRMLQRRIGLEPFMRVLHRVLT 513
Cdd:pfam01433  143 NVNDPSEIDDIFDAIPYEKGASVLRMLETLLGEEVFQKGLRSYLK 187
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
233-513 8.76e-06

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 49.50  E-value: 8.76e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  233 CLDEPDQLALWELTFELEPHLVPVASGELEEKREVsENGKIRYKFHQTVPTSACNIGWAIGRFK-LEPHPESPTIYT-FS 310
Cdd:cd09601    131 CFDEPAFKATFDITITHPKGYTALSNMPPVESTEL-EDGWKTTTFETTPPMSTYLVAFVVGDFEyIESTTKSGVPVRvYA 209
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  311 LPGLepfVNHTTMYLD---KMVEFLEEKLSCRFPYPTLkvvfvDQcteeiqvysslLIVP-----------------TAM 370
Cdd:cd09601    210 RPGK---IEQGDFALEvapKILDFYEDYFGIPYPLPKL-----DL-----------VAIPdfaagamenwglityreTAL 270
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1254006585  371 LYHKKIIDVvqeARQKLIFS-----IALQFFGCLISPAQWWHWWIPVSIARFLTS-----LYVETKLGTAEARWQLKRAM 440
Cdd:cd09601    271 LYDPKTSSA---SDKQRVAEviaheLAHQWFGNLVTMKWWDDLWLNEGFATYMEYlavdkLFPEWNMWDQFVVDELQSAL 347
                          250       260       270       280       290       300       310
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1254006585  441 D-DVCDYEHqwgkivlsppeptkklPLHVDPRHEYTASPLYVEAMLKKGFLTMRMLQRRIGLEPFMRVLHRVLT 513
Cdd:cd09601    348 ElDSLASSH----------------PIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRKGLRKYLK 405
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH